Daniel Voytas
Daniel Voytas is a prominent American geneticist known for his pioneering work in the field of genome editing. He is a professor in the Department of Genetics, Cell Biology, and Development at the University of Minnesota. Voytas is also the Chief Science Officer at Calyxt, a company focused on developing healthier food ingredients through advanced plant breeding techniques.
Early Life and Education[edit | edit source]
Daniel Voytas was born in the United States. He earned his B.S. degree in Biochemistry from Harvard University. He then pursued his Ph.D. in Genetics at Harvard Medical School, where he conducted research on retrotransposons in yeast.
Career[edit | edit source]
After completing his Ph.D., Voytas conducted postdoctoral research at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology. He later joined the faculty at Iowa State University, where he began his work on plant genetics and genome editing.
In 2008, Voytas moved to the University of Minnesota, where he continued his research on genome engineering. He is best known for his contributions to the development of TALENs (Transcription Activator-Like Effector Nucleases) and CRISPR-Cas9 technologies, which have revolutionized the field of genetic engineering.
Research Contributions[edit | edit source]
Voytas' research has significantly advanced the understanding and application of genome editing technologies. His work on TALENs and CRISPR-Cas9 has enabled precise modifications to the genome of various organisms, including plants and animals. These technologies have broad applications in agriculture, medicine, and biotechnology.
TALENs[edit | edit source]
TALENs are engineered proteins that can be designed to target specific DNA sequences, allowing for precise genome editing. Voytas' work on TALENs has facilitated the development of crops with improved traits, such as disease resistance and enhanced nutritional content.
CRISPR-Cas9[edit | edit source]
CRISPR-Cas9 is a revolutionary genome editing tool that allows for targeted modifications to the DNA of living organisms. Voytas has been instrumental in adapting this technology for use in plants, enabling the creation of genetically modified crops with desirable traits.
Awards and Honors[edit | edit source]
Daniel Voytas has received numerous awards and honors for his contributions to the field of genetics and genome editing. Some of his notable accolades include:
- Election to the National Academy of Sciences
- Fellow of the American Association for the Advancement of Science
- McKnight Presidential Endowed Chair in Genomics
Personal Life[edit | edit source]
Voytas resides in Minnesota with his family. He continues to be actively involved in research and teaching at the University of Minnesota.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD